SecBot SecBot
3 ·Filed Jun 3, 2026

CVRX

CVRx, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001172346-26-000003
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

This is a routine Section 16 filing with no trading signal. Monitor future Form 4 filings by Michael D. Dale for any open-market purchases or sales that could provide insight into insider sentiment.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
CVRX ▼ -49.83% at T+60d
NEUTRAL call -49.83% · α vs SPY -51.71% · entry $5.88 → $2.95
Entry = T+0 close
Jun 3, 2026
via day close
T+1d
-8.50%
call -8.50% · α -5.91%
$5.38
settled 5mo ago
T+5d
-16.84%
call -16.84% · α -14.28%
$4.89
settled 5mo ago
T+20d
-4.76%
call -4.76% · α -3.39%
$5.60
settled 4mo ago
T+60d
-49.83%
call -49.83% · α -51.71%
$2.95
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Michael D. Dale filed a Form 3 initial statement of beneficial ownership with the SEC, indicating he has become an officer and/or director of CVRx, Inc. The filing includes a power of attorney authorizing designees to execute Section 16 filings on his behalf. This is a routine administrative filing with no material financial information or trading activity disclosed.

Key Facts

  • Michael D. Dale filed a Form 3 initial statement of beneficial ownership on June 3, 2026, with a period of report of June 1, 2026.
  • The filing includes a power of attorney authorizing Jared Oasheim, Joseph Johnson, Jordan Beckman, Amy C. Seidel, and Amra Hoso to execute Section 16 filings on his behalf.
  • No securities ownership amounts or transaction details are disclosed in the filing.
  • The filing is a standard requirement for new officers/directors under Section 16(a) of the Exchange Act.

Financial Impact

No financial impact — the filing contains no ownership amounts, transactions, or financial data.

Risk Factors

  • No material risks identified from this filing alone.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001172346-26-000003
Document: 0001172346-26-000003-index-headers.html0001172346-26-000003
Document: 0001172346-26-000003-index.html0001172346-26-000003
Document: 0001172346-26-000003.txt0001172346-26-000003
15 reports for CVRX
Performance horizon
40% Hit rate @ T+5 2 of 5 directional calls Went positive at some point 3 of 5 best @ T+60▲ +26.03%Mar 2, 2026
Filters
Rows
Reports for CVRX — sortable, filterable
TypeNow
Oct 22, 2026
3d ago
Press Release
NEUTRAL ★ 1/10
$1.37awaiting T+5—$1.38 (+1.09%)
Oct 2, 2026
23d ago
SC 13D/A
BEARISH ★ 7/10
$1.56 $1.48▲ +5.13%▲ +5.55%$1.38 (+11.22%)
Aug 11, 2026
10w ago
8-K
BEARISH ★ 5/10
$2.60 $2.75▼ −5.77%▼ −6.17%$1.38 (+46.73%)
Jul 23, 2026
13w ago
Press Release
NEUTRAL ★ 1/10
$4.74 $5.38▲ +13.50%▲ +13.13%$1.38 (−70.78%)
Jun 11, 2026
19w ago
Institutional Cluster
BULLISH ★ 4/10
$5.03 $4.95▼ −1.59%▼ −2.26%$1.38 (−72.47%)
Jun 9, 2026
19w ago
8-K
NEUTRAL ★ 3/10
$5.20 $4.98▼ −4.23%▼ −6.64%$1.38 (−73.37%)
Jun 9, 2026
19w ago
Press Release
NEUTRAL ★ 5/10
$5.20 $4.98▼ −4.23%▼ −6.64%$1.38 (−73.37%)
Jun 3, 2026
20w ago
3
NEUTRAL ★ 2/10
$5.88 $4.89▼ −16.84%▼ −14.28%$1.38 (−76.45%)
May 11, 2026
23w ago
8-K
NEUTRAL ★ 5/10
$5.27 $5.94▲ +12.71%▲ +12.64%$1.38 (−73.72%)
Apr 27, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$7.48 $7.80▲ +4.21%▲ +2.52%$1.38 (−81.48%)
Showing 10 of 15

US Market Status

Market Open — Closes in 6h 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 3, 2026